Document is current
Any future updates will be listed below
-
Authors
Rezende, Nathane Braga da Silva https://orcid.org/0000-0003-2942-6622
de Queiroz Barros-Aragão, Fernanda Gomes
Pinto, Talita
Crelier, Viviane Tavares Carvalho
Figueiredo, Marcos Ravi
Brandão, Carlos Otávio
de Souza, Andrea Silveira https://orcid.org/0000-0002-1553-2312
Tovar-Moll, Fernanda
de Freitas, Gabriel R. https://orcid.org/0000-0003-3178-0460
- License Information
-
More Information
Article History
Received: 12 April 2024
Accepted: 6 December 2024
First Online: 20 January 2025
Declarations
:
: This study is part of a project entitled ISARIC/WHO Clinical Characterization Protocol for Severe Emerging Infections: Coronavirus. Approved by the National Ethics and Research Committee, by the Instituto D’Or de Pesquisa e Ensino (CONEP-CAAE 29496920.8.0000.5262, 19 March, 2020), with an individual patient consent waiver. All authors have read and consented to the publication of this manuscript.
: Written informed consent was obtained from the patients for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal, and in the instance of the patient who passed away, written informed consent was obtained from the patient’s next-of-kin for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
: None of the authors report relevant financial or nonfinancial competing interests.
